|
|
 Previous Article | Table of Contents | Next Article 
Molecular analysis of chromosome 20q deletions associated with
myeloproliferative disorders and myelodysplastic syndromes
FA Asimakopoulos, NJ White, E Nacheva and AR Green
Department of Haematology, University of Cambridge, MRC Centre, UK.
Acquired deletions of the long arm of chromosome 20 are found in several
hematologic conditions and particularly in the myeloproliferative disorders
and myelodysplastic syndromes. The spectrum of diseases associated with 20q
deletions suggests that such deletions may mark the site of a tumor
suppressor gene that contributes to the regulation of normal multipotent
hematopoietic progenitors. We present here the first detailed molecular
analysis of 20q deletions associated with myeloid disorders. Thirty-four
microsatellite primer pairs corresponding to loci on 20q have been used to
study DNA samples from two cell lines and from highly purified peripheral
blood granulocytes obtained from seven patients. In addition, Southern
analysis of cell line DNA has been performed using 19 DNA probes that map
to 20q. Three conclusions can be drawn from our results. Firstly, molecular
heterogeneity of both centromeric and telomeric breakpoints was
demonstrated, thus supporting the existence of a tumor suppressor gene on
20q. In addition many of the breakpoints have been mapped to small genetic
intervals. Secondly, our results define a commonly deleted region of 16-21
cM which contains ADA, PLC1, TOP1, SEMG1, and PPGB. Several candidate tumor
suppressor genes lie outside the common deleted region including SRC, HCK,
p107, PTPN1, and CEBP beta. Thirdly, the data allow integration of genetic
and physical maps and have refined the map positions of multiple genes.
These results will facilitate attempts to identify candidate hematopoietic
tumor suppressor genes on 20q.
Volume 84,
Issue 9,
pp. 3086-3094,
11/01/1994
Copyright © 1994 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
F. X. Schaub, R. Jager, R. Looser, H. Hao-Shen, S. Hermouet, F. Girodon, A. Tichelli, H. Gisslinger, R. Kralovics, and R. C. Skoda
Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F
Blood,
February 26, 2009;
113(9):
2022 - 2027.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. L. Levine and D. G. Gilliland
Myeloproliferative disorders
Blood,
September 15, 2008;
112(6):
2190 - 2198.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Skoda
The Genetic Basis of Myeloproliferative Disorders
Hematology,
January 1, 2007;
2007(1):
1 - 10.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Rogers, Y. Joe, T. Manshouri, A. Dey, I. Jilani, F. Giles, E. Estey, E. Freireich, M. Keating, H. Kantarjian, et al.
Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia
Blood,
April 1, 2004;
103(7):
2799 - 2801.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Mori, R. Morosetti, E. Hoflehner, M. Lubbert, H. Mizoguchi, and H. P. Koeffler
Allelic Loss in the Progression of Myelodysplastic Syndrome
Cancer Res.,
June 1, 2000;
60(11):
3039 - 3042.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. C. Pearson, M. Messinezy, N. Westwood, A. R. Green, A. J. Bench, A. R. Green, B. J.P. Huntly, E. P. Nacheva, T. Barbui, and G. Finazzi
A Polycythemia Vera Update: Diagnosis, Pathobiology, and Treatment
Hematology,
January 1, 2000;
2000(1):
51 - 68.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. LeCouter, B. Kablar, W. R. Hardy, C. Ying, L. A. Megeney, L. L. May, and M. A. Rudnicki
Strain-Dependent Myeloid Hyperplasia, Growth Deficiency, and Accelerated Cell Cycle in Mice Lacking the Rb-Related p107 Gene
Mol. Cell. Biol.,
December 1, 1998;
18(12):
7455 - 7465.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
N. Mori, R. Morosetti, S. Lee, S. Spira, D. Ben-Yehuda, G. Schiller, R. Landolfi, H. Mizoguchi, and H. P. Koeffler
Allelotype Analysis in the Evolution of Chronic Myelocytic Leukemia
Blood,
September 1, 1997;
90(5):
2010 - 2014.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
